Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Antibody Drug Conjugates Market By Product Type (Kadcyla, Adcertis, Others), By Application (Leukemia, Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Antibody Drug Conjugates Market size is valued at USD 4.84 billion in 2021 and is expected to reach USD 9.87 billion by 2028, at a CAGR of 12.6% during the forecast period 2022-2028. ADCs are a type of biopharmaceutical used to treat cancer that consists of an antibody that selectively targets a tumour antigen and a cytotoxic agent linked together by a chemical linker. ADCs are designed to allow the cytotoxic substance to be targeted specifically to kill cancer cells while having a minimal effect on healthy tissue. Antibody drug conjugates are made up of three parts: an antibody specific for the target associated antigen, an antigen that has limited expression on normal cells, a cytotoxic agent that kills target cancer cells, and a chemical linker that connects the cytotoxic agent to the antibody. Antibody drug conjugates have therapeutic potential but face technological and developmental obstacles. Antibody drug conjugates are thought to be the next generation of therapeutics. They combine the ability of monoclonal antibodies to target specific cells with the ability of cytotoxic medicines to kill those cells. Only with rising technological developments has this technology been able to succeed. Antibody drug conjugates are a new therapeutic class that is attracting the attention of both large and small pharmaceutical businesses. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Antibody Drug Conjugates Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Antibody Drug Conjugates Market

MARKET SUMMARY
-
12.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.6%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Antibody Drug Conjugates Market

  • The global Antibody Drug Conjugates Market report gives comprehensive outlook on Antibody Drug Conjugates Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Antibody Drug Conjugates Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
  • In September 2017, Pfizer, Inc. received FDA approval for the Mylotarg (Gemtuzumab Ozogamicin), and antibody drug conjugate used in newly diagnosed and relapsed or refractory CD33-Positive acute myeloid leukemia.
key players
  • Roche Holding AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Bayer HealthCare (Germany)
  • Progenics Pharmaceuticals (U.S.)
  • Roche Holding AG (Switzerland)
Antibody Drug Conjugates Market

DRIVERS AND RESTRAINTS

The advancement of medical technology is projected to fuel the global market for antibody drug conjugates. The market’s main drivers include an increase in cancer incidence, a growing elderly population, and an increase in obese people.


North-America got significant share

Antibody Drug Conjugates Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

Antibody Drug Conjugates Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

  1. Table of Content
  2. Executive Summary
  3. Global Antibody Drug Conjugates Market Introduction
    • Global Antibody Drug Conjugates Market – Taxonomy
    • Global Antibody Drug Conjugates Market –Definitions
      • Product Type
      • Application
      • Distribution Channel
  1. Global Antibody Drug Conjugates Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Antibody Drug Conjugates Market Dynamic Factors – Impact Analysis
    • Global Antibody Drug Conjugates Market – Competition Landscape
    • Epidemiology
  2. Global Antibody Drug Conjugates Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Antibody Drug Conjugates Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Kadcyla
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Adcertis
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026
    • Leukemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lymphoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel and Region, 2020 – 2026
  2. North America Antibody Drug Conjugates Market Analysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2020 – 2026
    • North America Antibody Drug Conjugates Market Dynamics – Trends
  3. Europe Antibody Drug Conjugates Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Europe Antibody Drug Conjugates Market Dynamics – Trends
  4. Asia-Pacific Antibody Drug Conjugates Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Asia-Pacific Antibody Drug Conjugates Market Dynamics – Trends
  5. Latin America Antibody Drug Conjugates Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Latin America Antibody Drug Conjugates Market Dynamics – Trends
  6. Middle East and Africa Antibody Drug Conjugates Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2020 – 2026
    • MEA Antibody Drug Conjugates Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Roche Holding AG (Switzerland)
      • Pfizer Inc. (U.S.)
      • Bayer HealthCare (Germany)
      • Progenics Pharmaceuticals (U.S.)
      • ImmunoGen, Inc. (U.S.)
      • Celldex Therapeutics (U.S.)
      • AbbVie Inc. (U.S.)
      • Millennium Pharmaceuticals (U.S.)
      • Agensys, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • Roche Holding AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Bayer HealthCare (Germany)
  • Progenics Pharmaceuticals (U.S.)
  • Roche Holding AG (Switzerland)
  • ImmunoGen, Inc. (U.S.)
  • Celldex Therapeutics (U.S.)
  • AbbVie Inc. (U.S.)
  • Millennium Pharmaceuticals (U.S.)
  • Agensys, Inc. (U.S.)

Report

Ask An Analyst

 

Description

Antibody Drug Conjugates Market size is valued at USD 4.84 billion in 2021 and is expected to reach USD 9.87 billion by 2028, at a CAGR of 12.6% during the forecast period 2022-2028. ADCs are a type of biopharmaceutical used to treat cancer that consists of an antibody that selectively targets a tumour antigen and a cytotoxic agent linked together by a chemical linker. ADCs are designed to allow the cytotoxic substance to be targeted specifically to kill cancer cells while having a minimal effect on healthy tissue. Antibody drug conjugates are made up of three parts: an antibody specific for the target associated antigen, an antigen that has limited expression on normal cells, a cytotoxic agent that kills target cancer cells, and a chemical linker that connects the cytotoxic agent to the antibody. Antibody drug conjugates have therapeutic potential but face technological and developmental obstacles. Antibody drug conjugates are thought to be the next generation of therapeutics. They combine the ability of monoclonal antibodies to target specific cells with the ability of cytotoxic medicines to kill those cells. Only with rising technological developments has this technology been able to succeed. Antibody drug conjugates are a new therapeutic class that is attracting the attention of both large and small pharmaceutical businesses. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Antibody Drug Conjugates Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX